Benitec Biopharma (id:6282 BNTC)
10.49 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/23/2024 3:53:53 PM)
Exchange closed, opens in 1 day 17 hours
About Benitec Biopharma
Market Capitalization 211.62M
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. Benitec Biopharma Inc. was incorporated in 1995 and is headquartered in Hayward, California.
| Headquarters (address) |
3940 Trust Way Hayward 94545 CA United States |
| Phone | 510 780 0819 |
| Website | https://benitec.com |
| Employees | 16 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | BNTC |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 2.69 - 12.89 |
| Market Capitalization | 211.62M |
| Dividend yield forward | 0.112 % |
| Dividend yield forward United States (ID:6, base:1865) | 4.13 % |
| P/E forward | -1.13 |
| Price/Book | 2.28 |
| Beta | 0.879 |
| EPS | -5.51 |
| EPS United States (ID:6, base:3402) | 24.25 |
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Benitec Biopharma has raised their dividend 0.112 years in a row. This is below the 41490.574800 year average in the 'Biotechnology' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Benitec Biopharma has raised their dividend 0.112 years in a row. This is below the 41490.574800 year average in the 'Biotechnology' industry